Post–COVID-19 New Normal for Nuclear Medicine Practice: An Australasian Perspective

The COVID19 pandemic has redefine the way nuclear medicine is practiced. The threat from COVID19 to health and to the nuclear medicine community is rapidly changing. During the acute phase of COVID19, there were significant direct and indirect impacts on nuclear medicine practice that have been previously detailed (1,2). It is useful to consider how COVID19 will shape nuclear medicine practice as we re-emerge from the acute phase (first wave) and prepare for both the second wave and practice after the COVID19 crisis. With the impact and the Government responses varying across the globe, there is some value in gleaning a global perspective. Here, a perspective from an Australian and New Zealand context is provided.

[1]  P. Barbey,et al.  When nuclear medicine radiological protection meets biological COVID-19 protection , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  F. Wuest,et al.  The Role of Nuclear Medicine for COVID-19: Time to Act Now , 2020, The Journal of Nuclear Medicine.

[3]  G. Currie COVID19 impact on nuclear medicine: an Australian perspective , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  J. Hatazawa,et al.  Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences , 2020, The Journal of Nuclear Medicine.